Prothena Corporation plc (PRTA)
NASDAQ: PRTA · IEX Real-Time Price · USD
22.04
+0.62 (2.89%)
At close: May 2, 2024, 4:00 PM
24.24
+2.20 (9.98%)
After-hours: May 2, 2024, 7:59 PM EDT

Prothena Corporation Revenue

In the year 2023, Prothena Corporation had annual revenue of $91.37M with 69.50% growth. Revenue in the quarter ending December 31, 2023 was $316.00K, a -99.37% decrease year-over-year.

Revenue (ttm)
$91.37M
Revenue Growth
+69.50%
P/S Ratio
12.96
Revenue / Employee
$528,150
Employees
173
Market Cap
1.18B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202391.37M37.47M69.50%
Dec 31, 202253.91M-146.67M-73.13%
Dec 31, 2021200.58M199.72M23,414.30%
Dec 31, 2020853.00K39.00K4.79%
Dec 31, 2019814.00K-141.00K-14.76%
Dec 31, 2018955.00K-26.56M-96.53%
Dec 31, 201727.52M26.46M2,508.44%
Dec 31, 20161.06M-552.00K-34.35%
Dec 31, 20151.61M-49.25M-96.84%
Dec 31, 201450.85M50.18M7,422.78%
Dec 31, 2013676.00K-1.98M-74.57%
Dec 31, 20122.66M2.15M424.26%
Dec 31, 2011507.00K-736.00K-59.21%
Dec 31, 20101.24M--
Dec 31, 20090--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Maravai LifeSciences Holdings 288.95M
MannKind 198.96M
Cronos Group 87.24M
Vir Biotechnology 86.18M
Immatics 60.00M
AbCellera Biologics 38.03M
Silence Therapeutics 32.12M
Bicycle Therapeutics 26.98M
Revenue Rankings